However, protocols extending beyond 6 months in humans rely on extrapolation rather than controlled studies
For comprehensive strategies on preventing weight regain after stopping treatment, see our complete retatrutide maintenance and weight regain guide
Before starting treatment, your provider will review or order: BMI and blood pressure measurement, fasting blood glucose or A1C, lipid profile, kidney and liver function, hormone levels if indicated by your history, and body composition analysis
However, when restricting to patients with prior electronic health records, the association was attenuated and nonsignificant (HR 1.03
The SURMOUNT-1 trial found that participants on tirzepatide 15mg achieved an average weight loss of 20.9% of body weight, while the STEP 1 trial found semaglutide 2.4mg produced an average of 14.9%